Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03051724
Other study ID # PI14/00416_1
Secondary ID
Status Completed
Phase N/A
First received February 7, 2017
Last updated February 22, 2018
Start date February 6, 2017
Est. completion date January 30, 2018

Study information

Verified date February 2018
Source Hospital Clinic of Barcelona
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obstructive sleep apnea is a very frequent syndrome and Continuous Positive Airway Pressure (CPAP) is the gold standard treatment. Nevertheless, obtaining the sufficient compliance is complex. New communication technologies and the current health challenges, such as aging and high health care costs have encouraged the interest in new strategies.

As showed recently, telemedicine is an alternative (Isetta, Thorax 2015) in patients that use internet and mobile technologies usually. However, there is a significant percentage of patients that does not use Internet and mobile technologies, only the 58% of patients over 65 years uses them (Dorsey, NEJM 2016). Although evidence regarding telemedicine is conflicting, it suggest that it's applicability depends in patient's characteristics and it is necessary to personalize it to make it safe and effective (Takahashi, Arch Intern Med 2012). That's why the investigators believe that the next step should be to choose those patient's that doesn't use Internet or mobile technologies and to verify the applicability of a telematic system that could facilitate the extra hospital management of this patient's.

The aim of the study is to evaluate the telematic management of various outcomes that are emitted by CPAP machine, and by an app where the patient's will answer different questions regarding their treatment during the three months of study period.


Description:

We include OSA patient's that are not familiarized with the use of internet and mobile technologies and with CPAP prescription. They follow up an adaptation session where an automatic CPAP machine is delivered. Patient's are titrated with this automatic device in 5-7 days and are treated with the automatic device during 3 months.

The other part of the follow up consists on a voicemail where the patient can contact the sleep unit 24h a day and on a tablet, with an special app where the patient's answer a questionnaire once two weeks.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 30, 2018
Est. primary completion date December 20, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- OSA diagnosis and CPAP prescription

- No use of internet or mobile devices

Exclusion Criteria:

- Unstable diseases and severe comorbidities

- Previous CPAP treatment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Telematic follow up
Follow-up of OSA patients through automatic CPAP with data transmission (Dreamstation; Philips Respironics), a 24-hour voice mailbox available for questions or problems, and an Internet-connected (4G) tablet with a friendly mobile application for simple questionnaires.

Locations

Country Name City State
Spain Hospital Clinic Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Hospital Clinic of Barcelona

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the telematic CPAP follow up CPAP adherence: Hours of use 3 months
Secondary Efficacy of titration and follow up of data transmitted by CPAP Leaks, Residual events 3 months
Secondary Evaluate the effects of treatment in patient's symptomatology Epworth questionnaire 3 months
Secondary Evaluate the satisfaction of patient's and professionals Satisfaction questionnaire 3 months
Secondary Evaluate the effect of CPAP treatment and telematic follow up EQ5D questionnaire 3 months
Secondary To compare the cost of the telematic follow up group vs hospital group Bayesian cost analysis 3 months
See also
  Status Clinical Trial Phase
Completed NCT05404438 - Mouth Breathing Habits Improvement Intervention N/A
Recruiting NCT05960175 - Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP N/A
Recruiting NCT05813275 - Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) Phase 3
Completed NCT05075668 - Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA N/A
Completed NCT05881512 - Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea N/A
Completed NCT03336515 - Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural) N/A
Not yet recruiting NCT05944965 - Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea Phase 1/Phase 2
Completed NCT02387476 - Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea N/A
Not yet recruiting NCT06058052 - Prevalence of OSA in Patients of ILD
Recruiting NCT03721445 - Could HRV be a Valuable Predictor for CPAP Adherence?
Completed NCT03172130 - Sham CPAP vs. Straight CPAP for Chronic Cough N/A
Recruiting NCT06320795 - Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device N/A
Completed NCT01717339 - Sleep Apnea and Vascular Function N/A
Completed NCT00772044 - Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea Phase 4
Recruiting NCT06400615 - Study That Tests AD109 in Patients Taking GLP-1 Drugs Phase 2
Completed NCT02438137 - Dimethyl Fumarate for Obstructive Sleep Apnea N/A
Completed NCT01672606 - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea N/A
Not yet recruiting NCT06110962 - Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
Completed NCT05060133 - Changes of the Upper Airway Volume After Orthognathic Surgery
Completed NCT03196583 - Efficacy of a Novel MAD in OSA N/A